Share

Our Company

May 11, 2018

Spotlight on Johnson & Johnson’s Bioethics Efforts

Spotlight on Johnson & Johnson’s Bioethics Efforts

Edwin Kuffner, M.D., Chief Medical Officer for Johnson & Johnson Consumer Inc.

May 04, 2018

The Answer for Indigenous Mothers? Native Midwives

The Answer for Indigenous Mothers? Native Midwives

Vàng Tả Mẩy, village ethnic minority midwife, with Chảo Tả Mẩy, a mother in Nậm Giang 2 village of Nậm Chạc commune, Bát Xát district, Lao Cai province

March 27, 2018

Read All About It! Our Epidemiology Publications Are Available to Anyone

Read All About It! Our Epidemiology Publications Are Available to Anyone

May 10, 2017

Scientific Excellence, Bioethics and Values-Driven Decision-Making

Scientific Excellence, Bioethics and Values-Driven Decision-Making

May 10, 2017

How our Scientific and Evidence-Based Approach to Real-World Evidence Helps Define Patient and Consumer Outcomes

How our Scientific and Evidence-Based Approach to Real-World Evidence Helps Define Patient and Consumer Outcomes

May 10, 2017

Preclinical Science: Driving Excellence in Safety at Johnson & Johnson

Preclinical Science: Driving Excellence in Safety at Johnson & Johnson

A photo of Gary Eichenbaum

March 10, 2021

A Message from Our Lead Director

A Message from Our Lead Director

March 10, 2021

To Our Shareholders

To Our Shareholders

December 18, 2020

Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021

Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021

December 17, 2020

Johnson & Johnson Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE is Fully Enrolled

Johnson & Johnson Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE is Fully Enrolled

December 01, 2020

Johnson & Johnson Announces the Initiation of a Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with Health Canada

Johnson & Johnson Announces the Initiation of a Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with Health Canada

December 01, 2020

Johnson & Johnson Announces Initiation of Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with the European Medicines Agency

Johnson & Johnson Announces Initiation of Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with the European Medicines Agency

See All Stories